Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis–associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects

Mitsuhiro Kawakubo(Nagoya University), Takayoshi Suganami(Nagoya Industrial Science Research Institute), Moritaka Goto(Riso Kagaku (Japan)), Miyako Tanaka(Nagoya Industrial Science Research Institute), Akiko Watanabe(Duke University), Ayaka Ito(Nagoya University Hospital), Naoki Yoshioka(Ogaki Municipal Hospital), Kozue Ochi(Nagoya University), Mitsuhiro Fujishiro(Bunkyo University), Masatoshi Ishigami(Nagoya University), Hiroshi Arima(Nagoya University), Yoshihiro Ogawa(Kyushu University), Yohei Kanamori(Kyoto University), Hiromi Suzuki(Nagoya University), Michiko Itoh(Tokyo Medical and Dental University), Makoto Sawada(Fujita Health University), Satoko Yamashita, Ibuki Shirakawa(Nagoya University), Sayaka Kanai(Tokyo Medical and Dental University), Marie Saka-Tanaka(Nagoya University)
Scientific Reports
January 22, 2020
Cited by 72


Related Papers